0

IN THIS ISSUE

JAMA: The Journal of the American Medical Association

July 10, 2002, Vol 288, No. 2
Theme: HIV/AIDS
Basic View  |  Expanded View
WaitingWaiting
Topics:
JAMA. 2002;288(2):142-142.  doi: 10.1001/jama.288.2.142
Dual vs Single Protease Inhibitor Therapy Following Antiretroviral Treatment Failure: Title and subTitle BreakA Randomized Trial FREE
Scott M. Hammer, MD; Florin Vaida, PhD; Kara K. Bennett, MS; Mary K. Holohan, BA; Lewis Sheiner, MD; Joseph J. Eron, MD; Lawrence Joseph Wheat, MD; Ronald T. Mitsuyasu, MD; Roy M. Gulick, MD; Fred T. Valentine, MD; Judith A. Aberg, MD; Michael D. Rogers, PhD; Cheryl N. Karol, PhD; Alfred J. Saah, MD, MPH; Ronald H. Lewis, MD; Laura J. Bessen, MD; Carol Brosgart, MD; Victor DeGruttola, PhD; John W. Mellors, MD; for the AIDS Clinical Trials Group 398 Study Team
Topics: abacavir, efavirenz, cd4 count determination procedure, indinavir, nelfinavir, protease inhibitor, reverse transcriptase inhibitors, saquinavir, treatment failure, viral load result, arm, amprenavir, adefovir dipivoxil, anti-retroviral agents, non-nucleoside reverse transcriptase inhibitors, virologic failure, adverse event
JAMA. 2002;288(2):169-180.  doi: 10.1001/jama.288.2.169
Time Trends in Primary HIV-1 Drug Resistance Among Recently Infected Persons FREE
Robert M. Grant, MD, MPH; Frederick M. Hecht, MD; Maria Warmerdam, BS; Lea Liu, MD, MSc; Teri Liegler, PhD; Christos J. Petropoulos, PhD; Nicholas S. Hellmann, MD; Margaret Chesney, PhD; Michael P. Busch, MD; James O. Kahn, MD
Topics: drug resistance, genotype, hiv-1, viral load result, anti-retroviral agents, non-nucleoside reverse transcriptase inhibitors
JAMA. 2002;288(2):181-188.  doi: 10.1001/jama.288.2.181
Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission: Title and subTitle BreakA Randomized Trial FREE
Alejandro Dorenbaum, MD; Coleen K. Cunningham, MD; Richard D. Gelber, PhD; Mary Culnane, MS, CRNP; Lynne Mofenson, MD; Paula Britto, MS; Claire Rekacewicz, MD; Marie-Louise Newell, PhD; Jean Francois Delfraissy, MD; Bethann Cunningham-Schrader, MS; Mark Mirochnick, MD; John L. Sullivan, MD; for the International PACTG 316 Team
Topics: nevirapine, anti-retroviral agents, perinatal period, hiv transmission, newborn care management
JAMA. 2002;288(2):189-198.  doi: 10.1001/jama.288.2.189
Hepatitis C and Progression of HIV Disease FREE
Mark S. Sulkowski, MD; Richard D. Moore, MD; Shruti H. Mehta, PhD, MPH; Richard E. Chaisson, MD; David L. Thomas, MD
Topics: hiv, acquired immunodeficiency syndrome, antiretroviral therapy, highly active, hepatitis c, cd4 count determination procedure, hiv infection, hepatitis c virus, anti-retroviral agents
JAMA. 2002;288(2):199-206.  doi: 10.1001/jama.288.2.199
Abacavir Substitution for Nucleoside Analogs in Patients With HIV Lipoatrophy: Title and subTitle BreakA Randomized Trial FREE
Andrew Carr, MD; Cassy Workman, MBBS; Don E. Smith, MD; Jennifer Hoy, MBBS; Jeff Hudson, RN; Nicholas Doong, MBBS, MPH; Allison Martin, MSc; Janaki Amin, MPH; Judith Freund, MBBS; Matthew Law, PhD; David A. Cooper, MD, DSc; for the Mitochondrial Toxicity (MITOX) Study Group
Topics: hiv, abacavir, lipodystrophy, stavudine, zidovudine, nucleoside analog, nucleoside analog antiviral
JAMA. 2002;288(2):207-215.  doi: 10.1001/jama.288.2.207
Real-time, Universal Screening for Acute HIV Infection in a Routine HIV Counseling and Testing Population FREE
Christopher D. Pilcher, MD; J. Todd McPherson, MS; Peter A. Leone, MD; Marlene Smurzynski, MSPH; Judy Owen-O'Dowd, BS; Amy L. Peace-Brewer, PhD; Juanita Harris, BS; Charles B. Hicks, MD; Joseph J. Eron, Jr, MD; Susan A. Fiscus, PhD
Topics: hiv, counseling, blood hiv rna, hiv infection
JAMA. 2002;288(2):216-221.  doi: 10.1001/jama.288.2.216
Clinician's Corner
Antiretroviral Treatment for Adult HIV Infection in 2002: Title and subTitle BreakUpdated Recommendations of the International AIDS Society-USA Panel
Patrick G. Yeni, MD; Scott M. Hammer, MD; Charles C. J. Carpenter, MD; David A. Cooper, MD, DSc; Margaret A. Fischl, MD; Jose M. Gatell, MD, PhD; Brian G. Gazzard, MA, MD; Martin S. Hirsch, MD; Donna M. Jacobsen, BS; David A. Katzenstein, MD; Julio S. G. Montaner, MD; Douglas D. Richman, MD; Michael S. Saag, MD; Mauro Schechter, MD, PhD; Robert T. Schooley, MD; Melanie A. Thompson, MD; Stefano Vella, MD; Paul A. Volberding, MD
Topics: acquired immunodeficiency syndrome, antiretroviral therapy, highly active, cd4 count determination procedure, protease inhibitor, viral load result, hiv infection, anti-retroviral agents
JAMA. 2002;288(2):222-235.  doi: 10.1001/jama.288.2.222
An Unequal Epidemic in an Unequal World
Kevin M. De Cock, MD, FRCP, DTM&H; Robert S. Janssen, MD
Topics: hiv, africa, epidemic
JAMA. 2002;288(2):236-238.  doi: 10.1001/jama.288.2.236
Emerging Resistance to Nonnucleoside Reverse Transcriptase Inhibitors: Title and subTitle BreakA Warning and a Challenge
Joel D. Trachtenberg, MD; Merle A. Sande, MD
Topics: non-nucleoside reverse transcriptase inhibitors
JAMA. 2002;288(2):239-241.  doi: 10.1001/jama.288.2.239
Does Hepatitis C Virus Infection Increase the Risk of HIV Disease Progression?
Stephen J. Rossi, PharmD; Paul A. Volberding, MD; Teresa L. Wright, MD
Topics: infection, hiv infection, hepatitis c virus
JAMA. 2002;288(2):241-243.  doi: 10.1001/jama.288.2.241
Preventing Mother-to-Child HIV Transmission: Title and subTitle BreakThe First Year of Thailand's National Program
Pornsinee Amornwichet, MPH; Achara Teeraratkul, MD; R. J. Simonds, MD; Thananda Naiwatanakul, MSc; Nartlada Chantharojwong, MSc; Mary Culnane, MS, CRNP; Jordan W. Tappero, MD, MPH; Siripon Kanshana, MD, MPH
Topics: hiv seropositivity, mothers, prenatal care, anti-retroviral agents, hiv transmission
JAMA. 2002;288(2):245-248.  doi: 10.1001/jama.288.2.245
Dignity-Conserving Care at the End of Life
Faye Girsh, EdD
Topics:
JAMA. 2002;288(2):162-162.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-288-2-jlt0710
Dignity-Conserving Care at the End of Life—Reply
Harvey Max Chochinov, MD, PhD, FRCPC
Topics:
JAMA. 2002;288(2):162-162.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-288-2-jlt0710
Loss of HIV-1–Specific Immunity During Treatment Interruption in 2 Chronically Infected Patients
Joel N. Blankson, MD, PhD; Joel E. Gallant, MD, MPH; Thomas C. Quinn, MD; John G. Bartlett, MD; Robert F. Siliciano, MD, PhD
Topics:
JAMA. 2002;288(2):162-164.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-288-2-jlt0710
HIV Seroprevalence of Adult Males Incarcerated for a Sexual Offense in Rhode Island, 1994-1999
Josiah D. Rich, MD, MPH; Grace Macalino, PhD; Roland C. Merchant, MD; Christopher Salas, BS; Pauline Marcussen, BS; Maureen Grundy, BA; Anne Spaulding, MD
Topics:
JAMA. 2002;288(2):164-165.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-288-2-jlt0710
Safety and Tolerability of Intermittent Rifampin/Pyrazinamide for the Treatment of Latent Tuberculosis Infection in Prisoners
Richard E. Chaisson, MD; Joan Armstrong, RN; John Stafford, MD, MPH; Jonathan Golub, MPH; Sarah Bur, RN, MPH
Topics:
JAMA. 2002;288(2):165-166.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-288-2-jlt0710
Policies for Exposure to Bloodborne Pathogens Among US-Based International Voluntary Medical Organizations
Alice Edler, MD; Margaret A. Olsen, PhD, MPH; M. C. E. Mbwille, ADAS
Topics:
JAMA. 2002;288(2):166-166.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-288-2-jlt0710
AIDS Knowledge Gap
Topics: acquired immunodeficiency syndrome
JAMA. 2002;288(2):155-155.  doi: 10.1001/jama.288.2.155
Health: A Pathway to Sustainable Development
Topics: hiv, acquired immunodeficiency syndrome, lung diseases, diarrhea, developing countries, food, health personnel, immunization, malaria, natural disasters, pesticides, poisons, respiration disorders, sound, toxin, tuberculosis, infection, unicef, advocacy, catabolism
JAMA. 2002;288(2):156-156.  doi: 10.1001/jama.288.2.156
Disseminated Infection With FREE
Topics: centers for disease control and prevention (u.s.), infection
JAMA. 2002;288(2):157-158.  doi: 10.1001/jama.288.2.157
Diagnosis of ExclusionDiagnosis of Exclusion
Topics:
JAMA. 2002;288(2):141-141.  doi: 10.1001/jama.288.2.141
Observations on Plague.Observations on Plague.
Topics:
JAMA. 2002;288(2):143-143.  doi: 10.1001/jama.288.2.143
Cheaper HIV Drugs for Poor Nations Bring a New Challenge: Monitoring Treatment
Topics: hiv
JAMA. 2002;288(2):151-153.  doi: 10.1001/jama.288.2.151
ImmunologyImmunology
Topics:
JAMA. 2002;288(2):250-250.  doi: 10.1001/jama.288.2.250
HIV Infection: The Basics FREE
Topics: hiv infection
JAMA. 2002;288(2):268-268.  doi: 10.1001/jama.288.2.268

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems